Humoral response 24 months after the first COVID-19 vaccination in people with HIV with and without diabetes

AIDS. 2024 Dec 1;38(15):2100-2103. doi: 10.1097/QAD.0000000000004026. Epub 2024 Nov 14.

Abstract

People with HIV (PWH) and people with diabetes mellitus have increased risk of severe COVID-19, but little is known about humoral response to COVID-19 vaccines in PWH with DM. We investigated SARS-CoV-2 antireceptor-binding domain (anti-RBD) immunoglobulin G (IgG) geometrical concentrations and neutralizing antibody capacity (nAB) in PWH with and without diabetes mellitus. Anti-RBD IgG and nAB in COVID-19-vaccinated PWH were not associated with diabetes mellitus-status or HbA1c 24 months after the initial COVID-19 vaccination.

MeSH terms

  • Adult
  • Aged
  • Antibodies, Neutralizing* / blood
  • Antibodies, Neutralizing* / immunology
  • Antibodies, Viral* / blood
  • COVID-19 Vaccines* / administration & dosage
  • COVID-19 Vaccines* / immunology
  • COVID-19* / complications
  • COVID-19* / immunology
  • COVID-19* / prevention & control
  • Diabetes Mellitus / immunology
  • Female
  • HIV Infections* / complications
  • HIV Infections* / immunology
  • Humans
  • Immunity, Humoral*
  • Immunoglobulin G* / blood
  • Immunoglobulin G* / immunology
  • Male
  • Middle Aged
  • SARS-CoV-2* / immunology
  • Vaccination

Substances

  • COVID-19 Vaccines
  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Immunoglobulin G